Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Healing | |||||
[46]
Systematic review |
147 people 2 RCTs in this analysis |
Proportion of ulcers completely healed
with dressings impregnated with silver with dressings not containing silver Absolute results not reported |
RR 1.66 95% CI 0.68 to 4.05 P = 0.27 |
Not significant | |
[48]
RCT |
251 people |
Proportion of responders (defined as people with a >20% reduction in ulcer area)
at 28 days
104/129 (81%) with ethacridine lactate (0.1% solution) twice daily 69/122 (57%) with placebo |
P <0.0001 |
Effect size not calculated | ethacridine lactate |
[49]
RCT |
119 people |
Proportion of people with completely healed ulcers
21/62 (34%) with 10% pale sulphonated shale oil 13/57 (23%) with vehicle (non-ionic gel) |
P = 0.177 |
Not significant | |
[49]
RCT |
119 people |
Reduction in ulcer area
72% with 10% pale sulphonated shale oil 19% with vehicle (non-ionic gel) Absolute numbers not reported |
P <0.001 |
Effect size not calculated | pale sulphonated shale oil |
[47]
Systematic review |
1188 people with leg wounds and ulcers 7 RCTs in this analysis |
Complete wound healing
68/574 (12%) with silver impregnated dressing 52/544 (10%) with non-silver dressing |
Risk difference for healing: +0.02 95% CI –0.01 to +0.06 P = 0.18 |
Not significant | |
[50]
RCT |
213 people with venous leg ulcers |
Ulcers healed
12 months
95/107 (89%) with silver-donating dressings 90/106 (85%) with non-silver low-adherence dressings |
RR 1.03 95% CI 0.51 to 2.08 |
Not significant |